Department of Neurosurgery, Xuanwu Hospital  2024-04-09 18:01 Beijing

Research programs

Xuanwu Hospital of Capital Medical University (CMU) is leading a prospective, multi-center clinical trial of nerve regeneration collagen scaffold graft for repair of acute complete spinal cord injury. We are now openly recruiting patients with acute complete spinal cord injury, and volunteers who meet the requirements will have the opportunity to participate in the clinical study. This clinical trial is also part of the 14th Five-Year National Key Research and Development Program "Research and Development of Biomaterials for Spinal Cord Injury Repair". The study has received ethical approval from Xuanwu Hospital of Capital Medical University (No. 037 of Clinical Examination [2022]).

Basic requirements for participation in the study

Patients with C4-T12 traumatic spinal cord injury within 14 days of injury, ASIA Grade A;

Imaging showing disruption of spinal cord integrity;

Electrophysiologic examination showing loss of sensory evoked potentials and motor evoked potentials in the lower limbs;

Aged between 18 and 65 years old, gender is not limited;

Good general condition with normal cardiovascular, respiratory, hepatic, renal and other major system functions; normal major indicators on routine laboratory tests;

Please consult the study physician for specific inclusion or exclusion criteria.

Patient benefits

Free provision of medical equipment for the study;

Free provision of relevant examinations;

Access to meticulous and comprehensive medical services from healthcare professionals;

Neurological function may be improved;

Matters requiring your cooperation

    Tell the study doctor about yourself, including your past illnesses, treatments you have received, and medications you have taken. You will be required to visit the hospital regularly, undergo various laboratory tests, and have quantitative blood samples collected so that the study doctor can be informed of the efficacy and safety of the investigational devices and safeguard your health.

Contact information

If you or someone close to you is interested in participating in this clinical trial, please contact us for more details and exclusion criteria.

Contact person and phone number: Dr. Ma 17600882871

Your personal information will be kept strictly confidential. Your participation will contribute to the advancement of medical science. We sincerely thank you for your participation.